StarZero All shows Try the podcast clipper →

Apr 22, 2017 · 26m · top-founders

637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Clate Mask · 12m spoken Nathan Latka · 9m spoken
0:00 / 0:00

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In this episode of The Top, host Nathan Latka interviews Infusionsoft CEO Clate Mask on scaling past $100M in ARR, overcoming an 8% monthly churn crisis, and choosing private late-stage funding over an IPO.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Nathan holds 43.7% of the talking time here. How this is scored →

Nathan as informed peer 5.0 Guest teaching 2.5 Guest disagreement 1.2 Nathan pushing back 1.8
05100:0010:0020:000:28–5:43 · Nathan as informed peer 5/10 Health Supplement Sponsorship and Travel Routine Nathan introduces Clate Mask and explores Infusionsoft's market positioning, pricing tiers, and embedded payment processing volume. The dynamic is polite and conversational as Clate explains moving into payments and utilizing customer volume for better interchange leverage.5:44–9:03 · Nathan as informed peer 6/10 Infusionsoft's Origins and Overcoming 8% Monthly Churn Nathan drills into the dark days of Infusionsoft, pressing Clate on specific metrics during their product-market fit crisis. Clate reveals their gross monthly customer churn hit nearly 8% after raising early venture rounds before they stabilized target accounts.9:04–13:10 · Nathan as informed peer 5/10 Capital Strategy, Investor Liquidity, and Organizational Growth Nathan inquires about investor secondary buyouts and attempts a quick revenue calculation by multiplying total users by average monthly account price. Clate corrects Nathan's assumption by explaining that user counts differ from paid account seats, prompting Nathan to recalibrate his math.13:10–15:34 · Nathan as informed peer 5/10 Why Infusionsoft Stayed Private Instead of Launching an IPO Nathan pushes Clate on why Infusionsoft did not go public alongside competitors like HubSpot. Clate breaks down how the late-stage private equity environment shifted IPO revenue requirements from $27M in previous decades up to $150M ARR today.15:34–19:09 · Nathan as informed peer 7/10 Unit Economics, Customer Filtering, and Setup Fee Strategy Nathan explores SaaS unit economics and identifies that Infusionsoft introduced a mandatory upfront onboarding fee to filter out high-churn solopreneurs. Clate confirms this strategy and criticizes competitors relying on unengaged breakage business models.19:10–23:15 · Nathan as informed peer 2/10 Sponsor Message: Travel Wellness Packets The segment includes sponsor spots and the rapid-fire Famous Five lightning round covering reading choices, sleep habits, family, and early entrepreneurial lessons.0:28–5:43 · Guest teaching 1/10 Health Supplement Sponsorship and Travel Routine Nathan introduces Clate Mask and explores Infusionsoft's market positioning, pricing tiers, and embedded payment processing volume. The dynamic is polite and conversational as Clate explains moving into payments and utilizing customer volume for better interchange leverage.5:44–9:03 · Guest teaching 2/10 Infusionsoft's Origins and Overcoming 8% Monthly Churn Nathan drills into the dark days of Infusionsoft, pressing Clate on specific metrics during their product-market fit crisis. Clate reveals their gross monthly customer churn hit nearly 8% after raising early venture rounds before they stabilized target accounts.9:04–13:10 · Guest teaching 5/10 Capital Strategy, Investor Liquidity, and Organizational Growth Nathan inquires about investor secondary buyouts and attempts a quick revenue calculation by multiplying total users by average monthly account price. Clate corrects Nathan's assumption by explaining that user counts differ from paid account seats, prompting Nathan to recalibrate his math.13:10–15:34 · Guest teaching 4/10 Why Infusionsoft Stayed Private Instead of Launching an IPO Nathan pushes Clate on why Infusionsoft did not go public alongside competitors like HubSpot. Clate breaks down how the late-stage private equity environment shifted IPO revenue requirements from $27M in previous decades up to $150M ARR today.15:34–19:09 · Guest teaching 3/10 Unit Economics, Customer Filtering, and Setup Fee Strategy Nathan explores SaaS unit economics and identifies that Infusionsoft introduced a mandatory upfront onboarding fee to filter out high-churn solopreneurs. Clate confirms this strategy and criticizes competitors relying on unengaged breakage business models.19:10–23:15 · Guest teaching 0/10 Sponsor Message: Travel Wellness Packets The segment includes sponsor spots and the rapid-fire Famous Five lightning round covering reading choices, sleep habits, family, and early entrepreneurial lessons.0:28–5:43 · Guest disagreement 1/10 Health Supplement Sponsorship and Travel Routine Nathan introduces Clate Mask and explores Infusionsoft's market positioning, pricing tiers, and embedded payment processing volume. The dynamic is polite and conversational as Clate explains moving into payments and utilizing customer volume for better interchange leverage.5:44–9:03 · Guest disagreement 1/10 Infusionsoft's Origins and Overcoming 8% Monthly Churn Nathan drills into the dark days of Infusionsoft, pressing Clate on specific metrics during their product-market fit crisis. Clate reveals their gross monthly customer churn hit nearly 8% after raising early venture rounds before they stabilized target accounts.9:04–13:10 · Guest disagreement 2/10 Capital Strategy, Investor Liquidity, and Organizational Growth Nathan inquires about investor secondary buyouts and attempts a quick revenue calculation by multiplying total users by average monthly account price. Clate corrects Nathan's assumption by explaining that user counts differ from paid account seats, prompting Nathan to recalibrate his math.13:10–15:34 · Guest disagreement 1/10 Why Infusionsoft Stayed Private Instead of Launching an IPO Nathan pushes Clate on why Infusionsoft did not go public alongside competitors like HubSpot. Clate breaks down how the late-stage private equity environment shifted IPO revenue requirements from $27M in previous decades up to $150M ARR today.15:34–19:09 · Guest disagreement 2/10 Unit Economics, Customer Filtering, and Setup Fee Strategy Nathan explores SaaS unit economics and identifies that Infusionsoft introduced a mandatory upfront onboarding fee to filter out high-churn solopreneurs. Clate confirms this strategy and criticizes competitors relying on unengaged breakage business models.19:10–23:15 · Guest disagreement 0/10 Sponsor Message: Travel Wellness Packets The segment includes sponsor spots and the rapid-fire Famous Five lightning round covering reading choices, sleep habits, family, and early entrepreneurial lessons.0:28–5:43 · Nathan pushing back 1/10 Health Supplement Sponsorship and Travel Routine Nathan introduces Clate Mask and explores Infusionsoft's market positioning, pricing tiers, and embedded payment processing volume. The dynamic is polite and conversational as Clate explains moving into payments and utilizing customer volume for better interchange leverage.5:44–9:03 · Nathan pushing back 2/10 Infusionsoft's Origins and Overcoming 8% Monthly Churn Nathan drills into the dark days of Infusionsoft, pressing Clate on specific metrics during their product-market fit crisis. Clate reveals their gross monthly customer churn hit nearly 8% after raising early venture rounds before they stabilized target accounts.9:04–13:10 · Nathan pushing back 3/10 Capital Strategy, Investor Liquidity, and Organizational Growth Nathan inquires about investor secondary buyouts and attempts a quick revenue calculation by multiplying total users by average monthly account price. Clate corrects Nathan's assumption by explaining that user counts differ from paid account seats, prompting Nathan to recalibrate his math.13:10–15:34 · Nathan pushing back 3/10 Why Infusionsoft Stayed Private Instead of Launching an IPO Nathan pushes Clate on why Infusionsoft did not go public alongside competitors like HubSpot. Clate breaks down how the late-stage private equity environment shifted IPO revenue requirements from $27M in previous decades up to $150M ARR today.15:34–19:09 · Nathan pushing back 2/10 Unit Economics, Customer Filtering, and Setup Fee Strategy Nathan explores SaaS unit economics and identifies that Infusionsoft introduced a mandatory upfront onboarding fee to filter out high-churn solopreneurs. Clate confirms this strategy and criticizes competitors relying on unengaged breakage business models.19:10–23:15 · Nathan pushing back 0/10 Sponsor Message: Travel Wellness Packets The segment includes sponsor spots and the rapid-fire Famous Five lightning round covering reading choices, sleep habits, family, and early entrepreneurial lessons.

speaking balance: gold is Nathan, purple is the guest (3 minute bins)

0:00 · Nathan 76.2% · guest 23.8%0:00 · Nathan 76.2% · guest 23.8%3:00 · Nathan 23.7% · guest 76.3%3:00 · Nathan 23.7% · guest 76.3%6:00 · Nathan 8.7% · guest 91.3%6:00 · Nathan 8.7% · guest 91.3%9:00 · Nathan 23.9% · guest 76.1%9:00 · Nathan 23.9% · guest 76.1%12:00 · Nathan 39.1% · guest 60.9%12:00 · Nathan 39.1% · guest 60.9%15:00 · Nathan 21.5% · guest 78.5%15:00 · Nathan 21.5% · guest 78.5%18:00 · Nathan 86.3% · guest 13.7%18:00 · Nathan 86.3% · guest 13.7%21:00 · Nathan 45.1% · guest 54.9%21:00 · Nathan 45.1% · guest 54.9%24:00 · Nathan 98.8% · guest 1.2%24:00 · Nathan 98.8% · guest 1.2%
Sharpest disagreement ▶ 16:13 Calling out competitor breakage models

Clate firmly rejects the standard SaaS playbook in the SMB market, dismissing competitors who run predatory 'gym models' with unengaged accounts and unsustainable churn.

 Hardest push from Nathan ▶ 13:15 Pressing on staying private versus IPO

Nathan directly challenges Clate on why Infusionsoft skipped the public markets when industry peers were going public, prompting Clate to quantify modern private equity alternatives.

 Biggest teaching moment ▶ 12:25 Differentiating user seats from billing accounts

Clate corrects Nathan's overestimation of company revenue by demonstrating that 135,000 active users represent shared team seats rather than individual paying subscription accounts.

 Nathan holds their own ▶ 18:33 Spotting the setup fee churn reduction lever

Nathan demonstrates sharp domain expertise by pinpointing that Infusionsoft's mandatory $1,000-$2,000 implementation fee was the primary driver in reducing monthly churn from 8% down to 2%.
the scores for every segment, with the reasoning behind each
ChapterTopicNathan as informed peerGuest teachingGuest disagreementNathan pushing backWhy
Health Supplement Sponsorship and Travel Routine 5111 Nathan introduces Clate Mask and explores Infusionsoft's market positioning, pricing tiers, and embedded payment processing volume. The dynamic is polite and conversational as Clate explains moving into payments and utilizing customer volume for better interchange leverage.
Infusionsoft's Origins and Overcoming 8% Monthly Churn 6212 Nathan drills into the dark days of Infusionsoft, pressing Clate on specific metrics during their product-market fit crisis. Clate reveals their gross monthly customer churn hit nearly 8% after raising early venture rounds before they stabilized target accounts.
Capital Strategy, Investor Liquidity, and Organizational Growth 5523 Nathan inquires about investor secondary buyouts and attempts a quick revenue calculation by multiplying total users by average monthly account price. Clate corrects Nathan's assumption by explaining that user counts differ from paid account seats, prompting Nathan to recalibrate his math.
Why Infusionsoft Stayed Private Instead of Launching an IPO 5413 Nathan pushes Clate on why Infusionsoft did not go public alongside competitors like HubSpot. Clate breaks down how the late-stage private equity environment shifted IPO revenue requirements from $27M in previous decades up to $150M ARR today.
Unit Economics, Customer Filtering, and Setup Fee Strategy 7322 Nathan explores SaaS unit economics and identifies that Infusionsoft introduced a mandatory upfront onboarding fee to filter out high-churn solopreneurs. Clate confirms this strategy and criticizes competitors relying on unengaged breakage business models.
Sponsor Message: Travel Wellness Packets 2000 The segment includes sponsor spots and the rapid-fire Famous Five lightning round covering reading choices, sleep habits, family, and early entrepreneurial lessons.

Statements from this episode (8)

Assertion Not checkable as stated
Mask: Infusionsoft core customers pay $250 to $300 per month
“So we focus on businesses that are two to 25 employees. The sweet spot for us really is two to 10 employees. That's where most of our customer base is. And on average, they're paying us between two 5300 bucks a month to get the benefits of sales and marketing …”
Clate Mask Apr 22, 2017 ▶ 3:19
Disclosure
Mask: Half of Infusionsoft's $125M funding went to secondary buyouts
“About one hundred and twenty five million, about half of which was capital for the business. [560] Nathan Latka: Okay. [560] Nathan Latka: Got it. [560] Nathan Latka: Versus what you, people were bought out earlier. [563] Nathan Latka: Investors already took r…”
Clate Mask Apr 22, 2017 ▶ 9:14
Disclosure
Mask: Infusionsoft reaches approximately 135,000 users in Q1 2017
“We've got about 135,000 users now”
Clate Mask Apr 22, 2017 ▶ 11:20
Assertion Supported
Mask: Tech IPO revenue benchmarks shifted from $27M to $150M
“One 50 is more like what it is today. The contact went public at twenty seven million.”
Clate Mask Apr 22, 2017 ▶ 13:42
Insight
Mask: Companies should always stay private if private capital exists
“We just felt like there's no, it's always better to stay private longer. So if you can and you can get the capital, then do it.”
Clate Mask Apr 22, 2017 ▶ 15:18
Disclosure
Mask: Infusionsoft rejects thousands of unqualified business leads monthly
“We have thousands and thousands of businesses every month that we say no to. In our lead qualification process, because they're not yet ready for Infusionsoft.”
Clate Mask Apr 22, 2017 ▶ 16:39
Disclosure
Mask: Infusionsoft's LTV to CAC ratio ranges between 3.5 and 4.5
“We range anywhere between three and a half and four and a half. That's kind of, you know, where we typically go.”
Clate Mask Apr 22, 2017 ▶ 17:16
Assertion Not checkable as stated
Mask: Upfront setup fees drove Infusionsoft's monthly churn from 8% to 2%
“Would you directly associate that upfront fee with being the number one mover of your churn going from eight to two percent? Absolutely.”
Clate Mask Apr 22, 2017 ▶ 18:50
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 2,600 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more